Rofecoxib is a nonsteroidal anti-inflammatory drug that was used in the treatment of osteoarthritis, acute pain conditions, and dysmenorrhoea.
Formerly marketed by Merck & Co.
under the trade names Vioxx, Ceoxx and Ceeoxx, it was voluntarily withdrawn from the market in 2004 because of concerns about increased risk of heart attack and stroke.
For more information about the topic Rofecoxib, read the full article at Wikipedia.org, or see the following related articles:
Editor's Note: This article is not intended to provide medical advice, diagnosis or treatment.
Recommend this page on Facebook, Twitter,
and Google +1:
Other bookmarking and sharing tools: